Chembio Diagnostics (CEMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,172 | 1,440 | 2,658 | 5,377 | 1,103 |
| Receivables | 4,208 | 4,580 | 4,897 | 2,423 | 9,515 |
| Inventories | 3,427 | 3,482 | 3,383 | 3,578 | 3,011 |
| TOTAL | $20,586 | $10,362 | $12,047 | $12,635 | $15,165 |
| Non-Current Assets | |||||
| PPE Net | 1,847 | 2,036 | 2,202 | 2,374 | 2,622 |
| Intangibles | 25 | 50 | 75 | 100 | 206 |
| Other Non-Current Assets | 227 | 242 | 5,848 | 5,707 | 4,815 |
| TOTAL | $2,099 | $2,328 | $8,125 | $8,182 | $7,643 |
| Total Assets | $22,685 | $12,689 | $20,172 | $20,816 | $22,808 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,588 | 2,708 | 2,416 | 2,801 | 4,414 |
| TOTAL | $3,041 | $3,527 | $2,761 | $3,155 | $4,564 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 453 | 819 | 345 | 353 | 150 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,041 | $3,527 | $2,761 | $3,155 | $4,564 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,027 | 11,986 | 9,651 | 9,628 | 9,628 |
| Common Shares | 120 | 97 | 97 | 96 | 96 |
| Retained earnings | -41,115 | -38,977 | -30,629 | -30,325 | -29,676 |
| TOTAL | $19,644 | $9,162 | $17,412 | $17,662 | $18,244 |
| Total Liabilities And Equity | $22,685 | $12,689 | $20,172 | $20,816 | $22,808 |